Načítá se...
Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
Venetoclax – a novel, orally bioavailable inhibitor of B-cell lymphoma-2 – has demonstrated substantial clinical activity in the treatment of chronic lymphocytic leukemia. Alone or in combination with other targeted agents, venetoclax results in high rate of durable responses and undetectable measur...
Uloženo v:
| Vydáno v: | Int J Hematol Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689538/ https://ncbi.nlm.nih.gov/pubmed/33294171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2020-0010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|